In response to this important clinical need, Scientists at the University of Ulster have developed a patent pending innovative technology for the production of aligned and non-aligned scaffolds from natural and synthetic polymers. The scaffolds are produced by the well-established electrospinning process in combination with a novel atmospheric pressure cold plasma treatment regime. The result is the formation of a scaffold matrix that is attractive to cells and capable to directing the formation of ECM.